Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis. - Test2 - elhamkhani - TriplyDB

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.

http://www.wikidata.org/entity/Q35753087

about

Telomerase Activation in Hematological Malignancies The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci The TERT rs2736100 polymorphism increases cancer risk: A meta-analysis Polymorphisms in human telomerase reverse transcriptase (hTERT) gene, gene- gene and gene-smoking interaction with susceptibility to gastric cancer in Chinese Han population Pharmacogenomics and the treatment of acute myeloid leukemia.The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.TERT promoter mutations in melanoma survival.Association between rs2853669 in TERT gene and the risk and prognosis of human cancer: a systematic review and meta-analysis Functional dissection of breast cancer risk-associated TERT promoter variants.TERT promoter status and gene copy number gains: effect on TERT expression and association with prognosis in breast cancer.Biological and clinical implications of telomere dysfunction in myeloid malignancies.Association between TERT rs2853669 polymorphism and cancer risk: A meta-analysis of 9,157 cases and 11,073 controls.Telomerase Reverse Transcriptase Polymorphism rs2736100: A Balancing Act between Cancer and Non-Cancer Disease, a Meta-Analysis.Telomere Maintenance Mechanisms in Cancer.

P2860

Q28068238-66877A73-CC33-4D0C-AE66-8746010DC488 Q28392404-6E7565A5-F6B9-471F-BE4D-6140F8DB3A25 Q28394349-A0B2A438-2561-4343-912A-C63706E20BF1 Q33888923-45957E02-B580-4A30-AA9C-00165F36CE45 Q37746294-22895F8D-D225-4803-A1C1-1CECD08ED18F Q38887034-BE65FB49-8BDF-440A-9227-711706742877 Q39095803-20615D3C-2A98-4A69-A5CD-F34A152F5B39 Q39998496-F681FE6A-BE1D-4A29-BDEA-ABD98795B678 Q41612491-B65D59F5-90C9-47F1-928E-ACCCDB773832 Q42366538-D1777AB5-7F89-4D76-815B-F79212CA9359 Q44378342-D6698FE5-A250-4F85-A60B-9B52EB520823 Q46980175-127C36C4-92A4-422F-AAD7-ECC2886B6383 Q52657990-C2982B6C-7848-492A-A32D-5ADBDDF707AD Q52726708-084DA2B7-8509-4A12-93D2-2C1E6DB49E3A Q55443450-56A66CD0-60DA-475B-9E46-99213C27A42E

P2860

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.

http://www.wikidata.org/entity/Q35753087

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Association between TERT promo ...... d leukemia risk and prognosis.

@ast

Association between TERT promo ...... d leukemia risk and prognosis.

@en

type

label

Association between TERT promo ...... d leukemia risk and prognosis.

@ast

Association between TERT promo ...... d leukemia risk and prognosis.

@en

prefLabel

Association between TERT promo ...... d leukemia risk and prognosis.

@ast

Association between TERT promo ...... d leukemia risk and prognosis.

@en

P1433

Q35753087-1F69C546-DEE5-4364-B2C5-7EF139C57F95

P1476

Q35753087-817E2FA9-87E7-412C-A8BE-4CE2221CF11C

P2093

Q35753087-0C069E03-D453-4152-B1F8-D5566A9E5FB8

Q35753087-1A429358-09F8-411A-B70B-56920BF205D7

Q35753087-42F5E202-78D5-46FA-BB6C-BE3E4259FBE6

Q35753087-54275698-706D-4F0A-9FBB-00CA5F77E092

Q35753087-BD444E63-0EDB-4C52-BBA0-302867E7CC82

Q35753087-C56A4F20-899E-4F68-9A0A-9FA020DB49CE

Q35753087-E0A875B4-3E31-4888-AB9F-091577909B84

Q35753087-FD264F4F-2CB6-418C-B321-1353A127ED3D

P2860

Q35753087-0469D0BC-C5F8-4BF9-AB07-9A7201F339EB

Q35753087-0BEEEBF1-6C90-49C9-BADF-B13BE7F8BF33

Q35753087-0E45B8E4-67C2-4FC0-9A5B-47243B5AA9D7

Q35753087-0E4B925D-687C-4525-B9CF-39E797EA5A4B

Q35753087-15FD7E11-19CA-46E5-9EDB-12AC8A9DAF46

Q35753087-16AD0BC1-93FF-49D3-BD61-AD95AF501DBE

Q35753087-1835A058-01CB-4FA4-A1F9-AEFBF0656417

Q35753087-1C226F49-C7AD-469F-AD58-11096E6A3F38

Q35753087-1F572D04-00B2-49FB-A7C9-729991D99CEC

Q35753087-25037288-5A67-4D64-B7EA-0ACDCDB36430

P304

Q35753087-B471CFCA-5EE0-4D78-8B35-6ADC2B09C17E

P31

Q35753087-449B7D25-4701-4598-8607-E5BC6F90A27D

P356

Q35753087-F9D74C9F-A18A-4A84-98A5-E71D25F04D25

P407

Q35753087-2DD1F40D-29F3-425D-846F-7523634A4792

P433

Q35753087-BAB650D2-AC52-49AA-8F51-3356AB2D6CC3

P478

Q35753087-9182CA07-99F4-4790-99BB-DB8F52C3EB7F

P50

Q35753087-6B43672A-DA15-416C-9C62-7B202BEA962E

P577

Q35753087-FBBA72D8-8E89-41F3-A37D-1BA70BF044D9

P5875

Q35753087-A93B7C8F-30F4-45D7-A454-D99B8ACED080

P698

Q35753087-08C4B102-DEE7-4384-A276-68F5ADD733BA

P921

Q35753087-D2AD49EE-A136-4E6A-8E84-788060E25FE6

P932

Q35753087-E88FEB66-FBF2-46F2-807B-2B630CC3D6DA

P356

ONCOTARGET.4668

P1433

P1476

Association between TERT promo ...... id leukemia risk and prognosis

@en

P2093

Dick Stockelberg

http://www.w3.org/2001/XMLSchema#string

Ingrid Jakobsen Falk

http://www.w3.org/2001/XMLSchema#string

Kerstin Willander

http://www.w3.org/2001/XMLSchema#string

Kourosh Lotfi

http://www.w3.org/2001/XMLSchema#string

Mohamed Ali Mosrati

http://www.w3.org/2001/XMLSchema#string

Monica Hermanson

http://www.w3.org/2001/XMLSchema#string

Peter Söderkvist

http://www.w3.org/2001/XMLSchema#string

Yuan Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Telomerase modulates Wnt signalling by association with target gene chromatin

Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT

Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro

POT1 loss-of-function variants predispose to familial melanoma

A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.

Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.

P304

25109-25120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.4668

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281486187

http://www.w3.org/2001/XMLSchema#string

P698

26298771

http://www.w3.org/2001/XMLSchema#string

P921

P932

4694818

http://www.w3.org/2001/XMLSchema#string